Antidote is a digital health company on a mission to accelerate the breakthrough in life-saving treatment by bridging the gap between medical research and the people who need it.
They use cutting-edge technology to match the right patients with the right trials, helping medical researchers make progress, faster and offering new treatment options to patients in need.
Antidote is helping accelerate medical research by transforming the way people connect to it. We are creating an ecosystem here, with an incredible combination of talent from tech and from the life sciences.
Sarah Kerruish, Chief Strategy and Growth Officer, Antidote
Report: A Digital Health Hub
We spoke to experts from industry, academia and the UK National Health Service (NHS) about the thriving digital health ecosystem.
Read the report to learn about the opportunities for you in the golden triangle of Cambridge, London and Oxford.
Meet Michael Seres, founder of 11 Health, a connected medical device company using Bluetooth technology to send secure real-time data to mobile devices. Michael founded 11 Health after having first-hand experience of stoma bag use following an intestinal transplant. He wanted to take back control of his life and spotted the need for a device that both patients and doctors could use for monitoring. This led to the development of the Ostom-I Alert Sensor.
Discover Cambridge Cognition, the company that translates gold standard neuroscience research into usable tools for doctors, researchers and patients. These tools make the drug development process more efficient, through their development of software based on new neuroscience insights from Cambridge University. The company are interested in not only helping to develop new drugs but also in how mobile health can: help to make drugs more effective and enable patients to better manage their health.
Discover Oxford company, Isansys Lifecare who with support from the Oxford Academic Health Science Network (AHSN) are creating a new class of data-driven biomarkers. Take the work they are doing with hepatologists at the Royal Free Hospital in London: the data from just one wireless wearable sensor patch taken over a 20-minute period is equivalent to the data and information content traditionally obtained from a blood test which takes hours of lab time and requires the patient to attend the hospital. This is a major shift towards data-driven methods.
Discover Px HealthCare, who utilized the NHS Innovation Accelerator as a UK launchpad for their OWise breast cancer app. In 2013, Px HealthCare launched its OWise breast cancer app in the Netherlands. The company had always intended to grow its business abroad. Having been selected for participation in the NHS Innovation Accelerator, and attracted by the appeal of the golden triangle of Cambridge, London and Oxford, it decided to relocate its centre of business operations to the UK from July 2015.